Publication | Open Access
Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study
255
Citations
8
References
2014
Year
Treatment of neuroendocrine tumors with radiolabeled sst antagonists is clinically feasible and may have a significant impact on peptide receptor radionuclide therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1